DocSym
β
Searchsearch
Search
(C81.2) Mixed cellularity classical hodgkin lymphoma
More details coming soon
1 166 892 in individuals diagnosis mixed cellularity classical hodgkin lymphoma confirmed
64 143 deaths with diagnosis mixed cellularity classical hodgkin lymphoma
6% mortality rate associated with the disease mixed cellularity classical hodgkin lymphoma
Diagnosis mixed cellularity classical hodgkin lymphoma is diagnosed Men are 14.89% more likely than Women
670 345
Men receive the diagnosis mixed cellularity classical hodgkin lymphoma
34 088 (5.1 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
496 547
Women receive the diagnosis mixed cellularity classical hodgkin lymphoma
30 055 (6.1 %)Died from this diagnosis.
Risk Group for the Disease mixed cellularity classical hodgkin lymphoma - Men aged 20-24 and Women aged 25-29
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 0-1, 95+Less common in women the disease occurs at Age 0-5, 95+
In Women diagnosis is most often set at age 5-94
Disease Features mixed cellularity classical hodgkin lymphoma
Absence or low individual and public risk
Mixed cellularity classical hodgkin lymphoma - what does this mean
Mixed cellularity classical hodgkin lymphoma is a type of cancer that occurs when abnormal lymphocytes, which are a type of white blood cell, grow and spread uncontrollably in the lymphatic system, leading to enlarged lymph nodes, fever, fatigue, and other symptoms. the cause of this type of lymphoma is unknown, but it is believed to be caused by a combination of genetic, environmental, and lifestyle factors.
What happens during the disease - mixed cellularity classical hodgkin lymphoma
Mixed cellularity classical hodgkin lymphoma is a type of cancer that develops in the lymphatic system. it is caused by a mutation in the b-cell lymphoma gene, which results in an uncontrolled proliferation of b-cells that form a tumor. this tumor then produces abnormal proteins and cytokines that cause inflammation and damage to the surrounding lymph nodes and organs. the tumor cells also release chemicals that attract other immune cells to the area, resulting in a mixed population of cells that can include lymphocytes, macrophages, and eosinophils. the combination of these cells leads to an increase in the tumor's size and spread throughout the body.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Complete blood count (CBC)
- Lymph node biopsy
- Imaging tests (CT scan, MRI, PET scan)
- Bone marrow biopsy
- Flow cytometry
- Cytogenetic studies
- Immunophenotyping
- Tumor marker tests
Treatment and Medical Assistance
Main goal: To reduce the size of the tumor and prevent the spread of the disease.
- Chemotherapy
- Radiotherapy
- Stem cell transplant
- Targeted therapy
- Immunotherapy
- Surgery
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Mixed cellularity classical hodgkin lymphoma - Prevention
The best way to prevent mixed cellularity classical hodgkin lymphoma is to practice healthy lifestyle habits such as avoiding smoking, maintaining a healthy weight, eating a balanced diet, and exercising regularly. additionally, it is important to get regular check-ups and screenings, as early detection and treatment can help reduce the risk of developing the disease.